A meta-analysis of 157 case-control studies reported the participation of XRCC3 T241M in the susceptibility for bladder and breast cancer, particularly in Caucasian individuals, and the XRCC3 T241M polymorphism was associated with a decreased risk of lung cancer (31). The gene discussed is XRCC3; the disease is breast carcinoma.